Login / Signup

Same-day Discharge Following Catheter Ablation and Venous Closure With VASCADE MVP: A Post-market Registry.

Zayd A EldadahAmin Al-AhmadThomas Jared BunchDavid B DeLurgioRahul N DoshiBruce G HookPatrick M HranitzkyCharles A JoynerSuneet MittalChristopher PorterfieldJavier E SanchezSenthil K ThambidoraiOussama M WazniH Thomas McElderry
Published in: Journal of cardiovascular electrophysiology (2022)
In this study, 99.7% of patients achieving SDD required no additional hospital intervention for access site-related complications during follow-up. SDD appears feasible and safe for eligible patients after catheter ablation for paroxysmal or persistent AF in which the VASCADE MVP is used for venous access-site closure. This article is protected by copyright. All rights reserved.
Keyphrases